ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results

BOSTON, June 26, 2012 /PRNewswire/ -- AG Mednet, Inc. today announced that it has signed an OEM agreement with ICON Medical Imaging, a division of ICON plc, further embedding AG Mednet's quality control, compliance, de-identification and image transfer technology into ICON's imaging trial offerings. AG Mednet provides the quality assurance and compliance technology necessary for clinical trials to operate with zero delay. The OEM partnership with AG Mednet provides ICON Medical Imaging with early insight into AG Mednet technology advancements for expanded capabilities, and will provide ICON's imaging clients with a more efficient, compliant and cost-effective clinical-trial system to expedite the clinical-trial decision-making process.

More than half of all image-related clinical trial query stoppages result from preventable human errors, according to industry research. On average, preventable mistakes delay a clinical trial for up to seven weeks, costing trial sponsors more than $8 million a day. AG Mednet's automated quality assurance technology reduces submission error rates at the source and brings preventable delays to zero.

ICON was the first imaging core laboratory to integrate with the AG Mednet solution, and this OEM agreement represents the culmination of a collaboration that recognizes AG Mednet as the industry leading solution for the collection of clinical trial medical images from study centers.  "The reductions in queries, data quality issues, and time-to-receipt are fundamental components in ICON's vision of a fully automated end-to-end, zero-delay clinical trial management environment for our sites and sponsors," said Andrew Kraus, Executive Vice President of ICON Global Data Technologies.

AG Mednet's technology and services will integrate with ICON's MIRA™ and CTMS to provide sponsors and sites with the most advanced image data collection and delivery system in the market. AG Mednet supports all organizations in the clinical trial ecosystem: core labs, clinical research organizations, pharmaceutical companies and principal investigators.

"This OEM agreement is the culmination of years of collaboration and hard work between our companies," said Abraham Gutman, President and CEO of AG Mednet. "ICON Medical Imaging has a far-reaching quality management vision that will reduce the burden on sites, increase trial efficiency and strengthen protocol compliance across all therapeutic areas."

For more information about AG Mednet's product suite that dramatically increases the overall quality, accuracy and consistency of a submission while significantly decreasing clinical trial queries, please visit www.agmednet.com/zerodelay.

About AG Mednet

AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, AG Mednet is the leading quality compliance partner for image data submission and collection for pharmaceutical, biotechnology and medical device companies, imaging core labs and clinical research organizations managing clinical trials globally. More than 14,000 registered users across thousands of investigator sites in 60 countries use AG Mednet to participate in projects sponsored by each of the world's top 20 pharmaceutical, biotech and medical device companies.

Media Contact:
Dawn Sullivan or Andrea Dunbeck
HB Agency
781-893-0053
[email protected]

SOURCE AG Mednet